HMP Global October 18, 2024
AMCP Nexus 2024 session speakers Kelly K. Makay, RPh MBA, Senior Consultant, BluePeak Advisors, and Crescent Moore, PharmD, PhD, Director, Part D/Pharmacy, BluePeak Advisors, explored the implications of the CY 2025 Medicare Part D Redesign and the Inflation Reduction Act, including the successes and challenges faced by stakeholders as they prepare for the changes ahead.
The Inflation Reduction Act of 2022, signed into law in August, includes provisions that will have a significant impact on Medicare, such as government authority to negotiate drug costs, changes to Medicare Part D benefits, and premium limitations. Additionally, the act enforces a maximum monthly cap on Part D cost-sharing.
“2025 is going to be one of the biggest years for the IRA because there is...
Today's Sponsors
Today's Sponsor